CHINA CRSC (03969) Income Statement & Earnings

3.360
0.0000.00%

15min DelayTrading Jun 15 09:20 CST

35.58BMarket Cap8.62P/E (TTM)

CHINA CRSC (03969) Income Statement

All

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q9)Sep 30, 2025

(Q6)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

Turnover

-3.52%6.46B

6.40%34.55B

4.48%21.75B

2.91%14.66B

2.93%6.7B

-12.24%32.47B

-15.48%20.81B

-14.33%14.25B

-13.10%6.51B

-7.96%37B

Special items of operating revenue

-6.86%30.87M

-27.00%124.55M

-25.20%94M

-20.78%64.92M

-12.90%33.14M

100.27%170.61M

118.50%125.67M

146.72%81.95M

204.98%38.05M

419.25%85.19M

Operating income

-3.54%6.5B

6.23%34.68B

4.31%21.84B

2.77%14.73B

2.84%6.73B

-11.98%32.64B

-15.17%20.94B

-14.00%14.33B

-12.74%6.55B

-7.79%37.09B

Operating expenses

3.78%-4.69B

-6.91%-24.57B

-6.99%-15.57B

-3.64%-10.45B

-3.19%-4.88B

16.48%-22.99B

20.84%-14.56B

19.24%-10.08B

18.42%-4.73B

10.30%-27.52B

Special items of gross profit

6.86%-30.87M

27.00%-124.55M

25.20%-94M

20.78%-64.92M

12.90%-33.14M

-100.27%-170.61M

-118.50%-125.67M

-146.72%-81.95M

-204.98%-38.05M

-419.25%-85.19M

Gross profit

-2.82%1.77B

5.18%9.98B

-1.35%6.17B

1.15%4.22B

2.24%1.82B

0.07%9.49B

0.31%6.26B

0.46%4.17B

5.04%1.78B

-0.44%9.48B

Selling expenses

-3.69%-170.49M

-1.64%-865.53M

8.16%-503.09M

4.46%-332.21M

5.65%-164.41M

-0.90%-851.58M

1.07%-547.81M

-1.37%-347.73M

-2.25%-174.26M

-3.93%-844M

Administrative expenses

-6.64%-523.14M

-1.60%-2.43B

0.74%-1.46B

-0.56%-961.29M

-0.49%-490.57M

-2.27%-2.39B

-0.55%-1.47B

1.47%-955.97M

-5.38%-488.17M

-2.00%-2.34B

Research and development expenses

-1.36%-384.78M

-4.88%-2.01B

-9.89%-1.28B

-6.99%-802.86M

-0.89%-379.61M

-2.69%-1.91B

-6.89%-1.16B

-15.68%-750.41M

-22.98%-376.27M

-10.21%-1.86B

Profit from asset sales

-130.60%-1.01M

88.09%79.37M

-105.71%-2.43M

-1,182.25%-485.24K

-35.42%-438.97K

66,149.68%42.2M

32,192.95%42.52M

-116.40%-37.84K

-766.67%-324.16K

-99.78%63.7K

Impairment and provision

696.18%27.24M

-2.47%-354.78M

34.76%-86.66M

55.23%-37.18M

-106.51%-4.57M

24.99%-346.22M

-40.07%-132.82M

-10.11%-83.05M

163.68%70.15M

17.15%-461.56M

-Other impairment is provision

696.18%27.24M

-2.47%-354.78M

34.76%-86.66M

55.23%-37.18M

-106.51%-4.57M

24.99%-346.22M

-40.07%-132.82M

-10.11%-83.05M

163.68%70.15M

17.15%-461.56M

Operating interest expense

16.76%-1.18M

72.32%-4.08M

72.58%-2.89M

62.35%-2.07M

-4.13%-1.42M

-1,910.81%-14.72M

-2,084.50%-10.54M

-3,704.17%-5.5M

---1.36M

---732.17K

Special items of operating profit

46.18%118.04M

-9.66%647.69M

5.55%433.76M

10.18%291.03M

-16.36%80.75M

11.88%716.91M

-6.24%410.94M

-20.37%264.14M

-27.77%96.55M

26.93%640.78M

Operating profit

-1.90%786.56M

7.06%4.77B

-3.67%3.11B

3.46%2.25B

-6.26%801.82M

2.07%4.45B

-3.14%3.23B

-7.00%2.17B

-2.71%855.37M

-2.37%4.36B

Financing income

-49.43%16.19M

-44.96%168.85M

-17.61%99.86M

-35.06%74.02M

-36.84%32.02M

-27.37%306.81M

-59.23%121.21M

-46.37%113.99M

-45.69%50.7M

3.68%422.43M

Financing cost

-188.01%-30.76M

-127.61%-86.78M

-141.70%-68.03M

-55.71%-38.02M

35.00%-10.68M

49.81%-38.13M

52.55%-28.15M

46.83%-24.42M

29.08%-16.43M

31.56%-75.97M

Special items of earning before tax

-180.01%-2.97M

100.71%86.89M

-63.01%8.1M

-26.01%6.36M

-47.07%3.72M

47.04%43.29M

54.90%21.9M

-14.97%8.59M

54.60%7.02M

-23.33%29.44M

Earning before tax

-8.53%752.98M

3.75%4.91B

-5.04%3.14B

0.96%2.28B

-7.16%823.22M

0.86%4.73B

-6.86%3.3B

-9.20%2.26B

-5.71%886.7M

-1.11%4.69B

After-tax profit from continuing operations

-5.57%615.96M

4.37%4.25B

-3.33%2.63B

0.13%1.86B

-8.49%652.3M

1.35%4.07B

-7.75%2.72B

-11.82%1.86B

-8.22%712.79M

-2.09%4.01B

Earning after tax

-5.57%615.96M

4.37%4.25B

-3.33%2.63B

0.13%1.86B

-8.49%652.3M

1.35%4.07B

-7.75%2.72B

-11.82%1.86B

-8.22%712.79M

-2.09%4.01B

Minority profit

4.29%94.51M

-2.40%560.45M

-4.43%347.75M

-7.30%241.26M

-16.32%90.62M

6.83%574.22M

-5.51%363.87M

-8.60%260.26M

9.73%108.3M

15.10%537.51M

Profit attributable to shareholders

-7.16%521.45M

5.48%3.69B

-3.16%2.28B

1.34%1.62B

-7.08%561.68M

0.50%3.49B

-8.09%2.36B

-12.32%1.6B

-10.84%604.49M

-4.30%3.48B

Basic earnings per share

0.00%0.05

6.25%0.34

0.00%0.22

0.00%0.15

-16.67%0.05

0.00%0.32

-8.33%0.22

-11.76%0.15

0.00%0.06

-3.03%0.32

Diluted earnings per share

0.00%0.05

6.25%0.34

0.00%0.22

0.00%0.15

-16.67%0.05

0.00%0.32

-8.33%0.22

-11.76%0.15

0.00%0.06

-3.03%0.32

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified Opinion

Auditor

Lixin Certified Public Accountants (Special General Partnership)

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q9)Sep 30, 2025	(Q6)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023
Turnover	-3.52%6.46B	6.40%34.55B	4.48%21.75B	2.91%14.66B	2.93%6.7B	-12.24%32.47B	-15.48%20.81B	-14.33%14.25B	-13.10%6.51B	-7.96%37B
Special items of operating revenue	-6.86%30.87M	-27.00%124.55M	-25.20%94M	-20.78%64.92M	-12.90%33.14M	100.27%170.61M	118.50%125.67M	146.72%81.95M	204.98%38.05M	419.25%85.19M
Operating income	-3.54%6.5B	6.23%34.68B	4.31%21.84B	2.77%14.73B	2.84%6.73B	-11.98%32.64B	-15.17%20.94B	-14.00%14.33B	-12.74%6.55B	-7.79%37.09B
Operating expenses	3.78%-4.69B	-6.91%-24.57B	-6.99%-15.57B	-3.64%-10.45B	-3.19%-4.88B	16.48%-22.99B	20.84%-14.56B	19.24%-10.08B	18.42%-4.73B	10.30%-27.52B
Special items of gross profit	6.86%-30.87M	27.00%-124.55M	25.20%-94M	20.78%-64.92M	12.90%-33.14M	-100.27%-170.61M	-118.50%-125.67M	-146.72%-81.95M	-204.98%-38.05M	-419.25%-85.19M
Gross profit	-2.82%1.77B	5.18%9.98B	-1.35%6.17B	1.15%4.22B	2.24%1.82B	0.07%9.49B	0.31%6.26B	0.46%4.17B	5.04%1.78B	-0.44%9.48B
Selling expenses	-3.69%-170.49M	-1.64%-865.53M	8.16%-503.09M	4.46%-332.21M	5.65%-164.41M	-0.90%-851.58M	1.07%-547.81M	-1.37%-347.73M	-2.25%-174.26M	-3.93%-844M
Administrative expenses	-6.64%-523.14M	-1.60%-2.43B	0.74%-1.46B	-0.56%-961.29M	-0.49%-490.57M	-2.27%-2.39B	-0.55%-1.47B	1.47%-955.97M	-5.38%-488.17M	-2.00%-2.34B
Research and development expenses	-1.36%-384.78M	-4.88%-2.01B	-9.89%-1.28B	-6.99%-802.86M	-0.89%-379.61M	-2.69%-1.91B	-6.89%-1.16B	-15.68%-750.41M	-22.98%-376.27M	-10.21%-1.86B
Profit from asset sales	-130.60%-1.01M	88.09%79.37M	-105.71%-2.43M	-1,182.25%-485.24K	-35.42%-438.97K	66,149.68%42.2M	32,192.95%42.52M	-116.40%-37.84K	-766.67%-324.16K	-99.78%63.7K
Impairment and provision	696.18%27.24M	-2.47%-354.78M	34.76%-86.66M	55.23%-37.18M	-106.51%-4.57M	24.99%-346.22M	-40.07%-132.82M	-10.11%-83.05M	163.68%70.15M	17.15%-461.56M
-Other impairment is provision	696.18%27.24M	-2.47%-354.78M	34.76%-86.66M	55.23%-37.18M	-106.51%-4.57M	24.99%-346.22M	-40.07%-132.82M	-10.11%-83.05M	163.68%70.15M	17.15%-461.56M
Operating interest expense	16.76%-1.18M	72.32%-4.08M	72.58%-2.89M	62.35%-2.07M	-4.13%-1.42M	-1,910.81%-14.72M	-2,084.50%-10.54M	-3,704.17%-5.5M	---1.36M	---732.17K
Special items of operating profit	46.18%118.04M	-9.66%647.69M	5.55%433.76M	10.18%291.03M	-16.36%80.75M	11.88%716.91M	-6.24%410.94M	-20.37%264.14M	-27.77%96.55M	26.93%640.78M
Operating profit	-1.90%786.56M	7.06%4.77B	-3.67%3.11B	3.46%2.25B	-6.26%801.82M	2.07%4.45B	-3.14%3.23B	-7.00%2.17B	-2.71%855.37M	-2.37%4.36B
Financing income	-49.43%16.19M	-44.96%168.85M	-17.61%99.86M	-35.06%74.02M	-36.84%32.02M	-27.37%306.81M	-59.23%121.21M	-46.37%113.99M	-45.69%50.7M	3.68%422.43M
Financing cost	-188.01%-30.76M	-127.61%-86.78M	-141.70%-68.03M	-55.71%-38.02M	35.00%-10.68M	49.81%-38.13M	52.55%-28.15M	46.83%-24.42M	29.08%-16.43M	31.56%-75.97M
Special items of earning before tax	-180.01%-2.97M	100.71%86.89M	-63.01%8.1M	-26.01%6.36M	-47.07%3.72M	47.04%43.29M	54.90%21.9M	-14.97%8.59M	54.60%7.02M	-23.33%29.44M
Earning before tax	-8.53%752.98M	3.75%4.91B	-5.04%3.14B	0.96%2.28B	-7.16%823.22M	0.86%4.73B	-6.86%3.3B	-9.20%2.26B	-5.71%886.7M	-1.11%4.69B
After-tax profit from continuing operations	-5.57%615.96M	4.37%4.25B	-3.33%2.63B	0.13%1.86B	-8.49%652.3M	1.35%4.07B	-7.75%2.72B	-11.82%1.86B	-8.22%712.79M	-2.09%4.01B
Earning after tax	-5.57%615.96M	4.37%4.25B	-3.33%2.63B	0.13%1.86B	-8.49%652.3M	1.35%4.07B	-7.75%2.72B	-11.82%1.86B	-8.22%712.79M	-2.09%4.01B
Minority profit	4.29%94.51M	-2.40%560.45M	-4.43%347.75M	-7.30%241.26M	-16.32%90.62M	6.83%574.22M	-5.51%363.87M	-8.60%260.26M	9.73%108.3M	15.10%537.51M
Profit attributable to shareholders	-7.16%521.45M	5.48%3.69B	-3.16%2.28B	1.34%1.62B	-7.08%561.68M	0.50%3.49B	-8.09%2.36B	-12.32%1.6B	-10.84%604.49M	-4.30%3.48B
Basic earnings per share	0.00%0.05	6.25%0.34	0.00%0.22	0.00%0.15	-16.67%0.05	0.00%0.32	-8.33%0.22	-11.76%0.15	0.00%0.06	-3.03%0.32
Diluted earnings per share	0.00%0.05	6.25%0.34	0.00%0.22	0.00%0.15	-16.67%0.05	0.00%0.32	-8.33%0.22	-11.76%0.15	0.00%0.06	-3.03%0.32
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	Unqualified Opinion	--	--	--	Unqualified Opinion	--	--	--	Unqualified Opinion
Auditor	--	Lixin Certified Public Accountants (Special General Partnership)	--	--	--	Lixin Certified Public Accountants (Special General Partnership)	--	--	--	Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"